Alan Shaw

11.2k total citations · 2 hit papers
109 papers, 9.2k citations indexed

About

Alan Shaw is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Alan Shaw has authored 109 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Immunology, 37 papers in Molecular Biology and 26 papers in Epidemiology. Recurrent topics in Alan Shaw's work include Immune Response and Inflammation (33 papers), Influenza Virus Research Studies (16 papers) and Immunotherapy and Immune Responses (14 papers). Alan Shaw is often cited by papers focused on Immune Response and Inflammation (33 papers), Influenza Virus Research Studies (16 papers) and Immunotherapy and Immune Responses (14 papers). Alan Shaw collaborates with scholars based in United States, Switzerland and France. Alan Shaw's co-authors include Michael P. Neeper, Ann Marie Schmidt, J Brett, Björn Högberg, Keith Elliston, Yacheng Pan, S D Yan, Fudi Wang, D Stern and Erik Benson and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Alan Shaw

108 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.

1992 1.3k citations Alan Shaw et al. profile →
Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.

1993 655 citations Alan Shaw et al. profile →

Peers

Countries citing papers authored by Alan Shaw

Since Specialization

Citations

This map shows the geographic impact of Alan Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Shaw more than expected).

Fields of papers citing papers by Alan Shaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Shaw. The network helps show where Alan Shaw may publish in the future.

Co-authorship network of co-authors of Alan Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Shaw. A scholar is included among the top collaborators of Alan Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Shaw. Alan Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Solid Phase Synthesis of DNA Nanostructures in Heavy Liquid 2022 ·Small ·Ioanna Smyrlaki, Alan Shaw, Yunshi Yang, Boxuan Shen, Björn Högberg	3
2	Single-molecule diffusometry reveals no catalysis-induced diffusion enhancement of alkaline phosphatase as proposed by FCS experiments 2020 ·Proceedings of the National Academy of Sciences ·Zhijie Chen, Alan Shaw, Hugh D. Wilson, Maxime Woringer, Xavier Darzacq, Susan Marqusee, Quan Wang, Carlos Bustamante	32
3	Spatial control of membrane receptor function using ligand nanocalipers 2014 ·Nature Methods ·Alan Shaw, Vanessa Lundin, Ekaterina Petrova, Ferenc Fördős, Erik Benson, (unknown), Anna Herland, Andries Blokzijl, Björn Högberg, Ana I. Teixeira	210
4	Imaging murine NALT following intranasal immunization with flagellin-modified circumsporozoite protein malaria vaccines 2013 ·Mucosal Immunology ·Adéla Nacer, Daniel Carapau, Robert A. Mitchell, (unknown), Alan Shaw, Ute Frevert, Elizabeth Nardin	26
5	DNA Origami Delivery System for Cancer Therapy with Tunable Release Properties 2012 ·ACS Nano ·Yongxing Zhao, Alan Shaw, Xianghui Zeng, Erik Benson, Andreas M. Nyström, Björn Högberg	418
6	Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response 2012 ·Vaccine ·David N. Taylor, John J. Treanor, Eric Sheldon, Casey Johnson, Scott Umlauf, Langzhou Song, Uma Kavita, Ge Liu, Lynda Tussey, (unknown), (unknown), Alan Shaw	102
7	Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI) 2011 ·Vaccine ·David N. Taylor, John J. Treanor, Cynthia Strout, Casey Johnson, Theresa Fitzgerald, Uma Kavita, (unknown), Lynda Tussey, Alan Shaw	132
8	Human papillomavirus vaccines in development: If they're successful in clinical trials, how will they be implemented? 2005 ·Gynecologic Oncology ·Alan Shaw	14
9	Regulation of Phytochrome B Nuclear Localization through Light-Dependent Unmasking of Nuclear-Localization Signals 2005 ·Current Biology ·Meng Chen, Yi Tao, Jason Lim, Alan Shaw, Joanne Chory	155
10	Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model 2004 ·Virology ·Leigh Zerboni, (unknown), Marvin Sommer, Hideki Ito, Jaya Besser, (unknown), Jason Cheng, Daniel J. DiStefano, (unknown), Alan Shaw, Ann M. Arvin	46
11	Rotavirus Immunoglobulin A Responses Stimulated by Each of 3 Doses of a Quadrivalent Human/Bovine Reassortant Rotavirus Vaccine 2004 ·The Journal of Infectious Diseases ·Richard L. Ward, David I. Bernstein, Vicki E. Smith, D. S. Sander, Alan Shaw, Joseph Eiden, Penny M. Heaton, Paul A. Offit, H. F. Clark	39
12	Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants 2004 ·The Journal of Pediatrics ·H. F. Clark, David I. Bernstein, Penelope H. Dennehy, Paul A. Offit, Michael E. Pichichero, John J. Treanor, Richard L. Ward, David L. Krah, Alan Shaw, Michael J. Dallas, (unknown), Joseph Eiden, Nathalie Ivanoff, Karen M. Kaplan, Penny M. Heaton	116
13	Comparative study of influenza virus replication in Vero and MDCK cell lines 2004 ·Journal of Virological Methods ·Rima Youil, Qin Su, Timothy J. Toner, (unknown), (unknown), Berish Y. Rubin, (unknown), Irina Kiseleva, Alan Shaw, (unknown)	66
14	Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors. 1996 ·Cineca Institutional Research Information System (Tor Vergata University) ·Maria Gabriella Torcia, Maria Lucibello, Edouard Vannier, S. Fabiani, A Miliani, Gabriele Guidi, (unknown), Steven Dower, John E. Sims, Alan Shaw, (unknown), Enrico Garaci, F Cozzolino	36
15	Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation 1995 ·Vaccine ·Kathrin U. Jansen, (unknown), Loren D. Schultz, Henry Z. Markus, James C. Cook, John Donnelly, Douglas Martinez, Ronald W. Ellis, Alan Shaw	144
16	Stimulation of human interleukin 1 production and specific mRNA expression by microtubule-disrupting drugs 1990 ·Cellular Immunology ·Bernard Ferruà, Serge N. Manié, Alain Doglio, Alan Shaw, (unknown), (unknown), (unknown)	29
17	Production of a 26,000-Dalton interleukin 1 inhibitor by human monocytes is regulated by granulocyte-macrophage colony-stimulating factor 1990 ·Cytokine ·John Shields, Lilia Bernasconi, (unknown), Alan Shaw, Gonzalo J. Mazzei	7
18	Interleukin‐1 Beta Gene Deregulation Associated With Chromosomal Rearrangement: A Candidate Initiating Event for Murine Radiation‐Myeloid Leukemogenesis? 1989 ·Molecular Carcinogenesis ·Andrew Silver, Jacqueline Boultwood, G. Breckon, W.K. Masson, Julie Adam, Alan Shaw, Roger Cox	17
19	Four different interleukin-1 species sensitize to the lethal action of Tumour Necrosis Factor 1989 ·Biochemical and Biophysical Research Communications ·Bart Everaerdt, Peter Brouckaert, Alan Shaw, Walter Fiers	43
20	Activation by PHA of CD8 lymphocytes into clonal colony forming cells 1988 ·Journal of Immunological Methods ·(unknown), J P Farcet, MF Gourdin, Marine Diviné, JP Marolleau, J Bouguet, J P Le Couedic, Alan Shaw, D Fradelizi, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact